| Name | Title | Contact Details |
|---|
MITY Incorporated is a worldwide leader in helping customers optimize their facilities with innovative furniture solutions. Our product brands MityLite®, Holsag®, Bertolini®, and XpressPort®. The products manufactured by our brands deliver the safety, ease of use, and functional design needed for businesses in industries such as hospitality, worship, education, senior living, restaurant, and government. With worldwide headquarters in Orem, Utah operating since 1987, MITY now has offices and manufacturing facilities in Tennessee, Missouri, and Ontario. QUALITY ENGINEERING: Detailed design and superior manufacturing go into every product built by MITY product brands. We stand by our strong warranty program and commitment to excellent customer service. INNOVATIVE PRODUCTS: ABS Folding Tables, stacking banquet chairs, folding chairs, portable dance floors, mobile banquet tables, and linenless tables with integrated power—we offer the best! OUR SECRET SAUCE: We have the most elite, creative, and passionate team of employees in the industry! They are committed to serving our business partners. Interested in joining our team or doing business with MITY? Email info@mityinc.com or call 800-909-8034.
Atosa is a major manufacturer of commercial kitchen equipment, with a breadth of offering including refrigeration, cooking equipment, warming/holding equipment, stainless steel fabrication equipment, and much more. Atosas world-class manufacturing facilities and highly skilled employees, combined with innovative manufacturing procedures ensure that our customers always receive top-quality products at economical prices.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.
TermScout is a Denver-based legal-tech company that helps businesses review contracts smarter and faster.